Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Saturday, May 24, 2025 · 815,769,390 Articles · 3+ Million Readers

Public Meeting on the Reauthorization of the Prescription Drug User Fee Act (PDUFA) - 07/14/2025


Date:
July 14, 2025
Time:
9:00 a.m. - 2:00 p.m. ET


The Food and Drug Administration (FDA or Agency) is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032. The public meeting will be held on July 14, 2025, from 9 a.m. to 2 p.m. For more background information on the meeting or to submit comments, please see the Federal Register notice with assigned docket FDA-2025-N-0816 issued on May 19, 2025. 

If you would like to attend the meeting, please register on Eventbrite

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release